StockWatch
·
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Corporate ActionJun 5, 2026, 08:31 AM

Nuwellis Prices Public Offering of Stock & Warrants for $6M

AI Summary

Nuwellis, Inc. announced the pricing of a public offering, aiming to raise approximately $6 million in gross proceeds. The offering consists of 20,000,000 shares of common stock (or pre-funded warrants) with accompanying Series C and Series D Warrants, priced at $0.30 per share and warrant. Both warrant series have an exercise price of $0.30, with Series C including a reset clause and Series D a zero cash exercise option, all subject to stockholder approval and a reverse stock split. Additionally, the company conducted a concurrent private placement to reprice existing warrants to $0.30.

Key Highlights

  • Nuwellis priced a public offering to raise approximately $6 million in gross proceeds.
  • The offering includes 20,000,000 shares of common stock (or pre-funded warrants) and accompanying warrants.
  • The public offering price is $0.30 per share of common stock and accompanying warrants.
  • Series C and Series D Warrants have an exercise price of $0.30 and are exercisable for five years post-stockholder approval and reverse stock split.
  • Series C Warrants include a one-time exercise price reset clause based on a reverse stock split.
  • Series D Warrants feature a zero cash exercise option.
  • A concurrent private placement repriced existing warrants to an exercise price of $0.30, subject to stockholder approval.